Gene expression profiling of granulosa cells from PCOS patients following varying doses of human chorionic gonadotropin

Serdar Coskun, Hasan H. Otu, Khalid A. Awartani, Laila A. Al-Alwan, Saad Al-Hassan, Hend Al-Mayman, Namik Kaya, Mehmet S. Inan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Purpose: Human chorionic gonadotrophin (hCG) has been used to induce ovulation and oocyte maturation. Although the most common dose of hCG used in IVF is 10,000 IU, there are reports that suggest 5,000 IU is sufficient to yield similar results. The objective of this study is to evaluate the dose dependent differences in gene expression of granulosa cells following various doses of hCG treatment. Methods: Patients with polycystic ovarian syndrome (PCOS) were stimulated for IVF treatment. The hCG injection was either withheld or given at 5,000 or 10,000 IU. Granulosa cells from the follicular fluids have been collected for RNA isolation and analyzed using Affymetrix genechip arrays. Results: Unsupervised hierarchical clustering based on whole gene expression revealed two distinct groups of patients in this experiment. All untreated patients were clustered together whereas hCG-treated patients separated to a different group regardless of the dose. A large number of the transcripts were similarly up- or down-regulated across both hCG doses (2229 and 1945 transcripts, respectively). However, we observed dose-dependent statistically significant differences in gene expression in only 15 transcripts. Conclusions: Although hCG injection caused a major change in the gene expression profile of granulosa cells, 10,000 IU hCG resulted in minimal changes in the gene expression profiles of granulosa cells as compared with 5,000 IU. Thus, based on our results, we suggest the use of 10,000 IU hCG should be reconsidered in PCOS patients.

Original languageEnglish (US)
Pages (from-to)341-352
Number of pages12
JournalJournal of Assisted Reproduction and Genetics
Volume30
Issue number3
DOIs
StatePublished - Mar 1 2013

Fingerprint

Granulosa Cells
Polycystic Ovary Syndrome
Gene Expression Profiling
Chorionic Gonadotropin
Transcriptome
Gene Expression
Follicular Fluid
Injections
Ovulation
Oocytes
Cluster Analysis
RNA
Therapeutics

Keywords

  • Gene expression
  • Granulosa cells
  • Microarray/PCOS
  • hCG

ASJC Scopus subject areas

  • Reproductive Medicine
  • Genetics
  • Obstetrics and Gynecology
  • Developmental Biology
  • Genetics(clinical)

Cite this

Gene expression profiling of granulosa cells from PCOS patients following varying doses of human chorionic gonadotropin. / Coskun, Serdar; Otu, Hasan H.; Awartani, Khalid A.; Al-Alwan, Laila A.; Al-Hassan, Saad; Al-Mayman, Hend; Kaya, Namik; Inan, Mehmet S.

In: Journal of Assisted Reproduction and Genetics, Vol. 30, No. 3, 01.03.2013, p. 341-352.

Research output: Contribution to journalArticle

Coskun, Serdar ; Otu, Hasan H. ; Awartani, Khalid A. ; Al-Alwan, Laila A. ; Al-Hassan, Saad ; Al-Mayman, Hend ; Kaya, Namik ; Inan, Mehmet S. / Gene expression profiling of granulosa cells from PCOS patients following varying doses of human chorionic gonadotropin. In: Journal of Assisted Reproduction and Genetics. 2013 ; Vol. 30, No. 3. pp. 341-352.
@article{8cbd4179667941f1ae528daea5616d89,
title = "Gene expression profiling of granulosa cells from PCOS patients following varying doses of human chorionic gonadotropin",
abstract = "Purpose: Human chorionic gonadotrophin (hCG) has been used to induce ovulation and oocyte maturation. Although the most common dose of hCG used in IVF is 10,000 IU, there are reports that suggest 5,000 IU is sufficient to yield similar results. The objective of this study is to evaluate the dose dependent differences in gene expression of granulosa cells following various doses of hCG treatment. Methods: Patients with polycystic ovarian syndrome (PCOS) were stimulated for IVF treatment. The hCG injection was either withheld or given at 5,000 or 10,000 IU. Granulosa cells from the follicular fluids have been collected for RNA isolation and analyzed using Affymetrix genechip arrays. Results: Unsupervised hierarchical clustering based on whole gene expression revealed two distinct groups of patients in this experiment. All untreated patients were clustered together whereas hCG-treated patients separated to a different group regardless of the dose. A large number of the transcripts were similarly up- or down-regulated across both hCG doses (2229 and 1945 transcripts, respectively). However, we observed dose-dependent statistically significant differences in gene expression in only 15 transcripts. Conclusions: Although hCG injection caused a major change in the gene expression profile of granulosa cells, 10,000 IU hCG resulted in minimal changes in the gene expression profiles of granulosa cells as compared with 5,000 IU. Thus, based on our results, we suggest the use of 10,000 IU hCG should be reconsidered in PCOS patients.",
keywords = "Gene expression, Granulosa cells, Microarray/PCOS, hCG",
author = "Serdar Coskun and Otu, {Hasan H.} and Awartani, {Khalid A.} and Al-Alwan, {Laila A.} and Saad Al-Hassan and Hend Al-Mayman and Namik Kaya and Inan, {Mehmet S.}",
year = "2013",
month = "3",
day = "1",
doi = "10.1007/s10815-013-9935-y",
language = "English (US)",
volume = "30",
pages = "341--352",
journal = "Journal of Assisted Reproduction and Genetics",
issn = "1058-0468",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Gene expression profiling of granulosa cells from PCOS patients following varying doses of human chorionic gonadotropin

AU - Coskun, Serdar

AU - Otu, Hasan H.

AU - Awartani, Khalid A.

AU - Al-Alwan, Laila A.

AU - Al-Hassan, Saad

AU - Al-Mayman, Hend

AU - Kaya, Namik

AU - Inan, Mehmet S.

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Purpose: Human chorionic gonadotrophin (hCG) has been used to induce ovulation and oocyte maturation. Although the most common dose of hCG used in IVF is 10,000 IU, there are reports that suggest 5,000 IU is sufficient to yield similar results. The objective of this study is to evaluate the dose dependent differences in gene expression of granulosa cells following various doses of hCG treatment. Methods: Patients with polycystic ovarian syndrome (PCOS) were stimulated for IVF treatment. The hCG injection was either withheld or given at 5,000 or 10,000 IU. Granulosa cells from the follicular fluids have been collected for RNA isolation and analyzed using Affymetrix genechip arrays. Results: Unsupervised hierarchical clustering based on whole gene expression revealed two distinct groups of patients in this experiment. All untreated patients were clustered together whereas hCG-treated patients separated to a different group regardless of the dose. A large number of the transcripts were similarly up- or down-regulated across both hCG doses (2229 and 1945 transcripts, respectively). However, we observed dose-dependent statistically significant differences in gene expression in only 15 transcripts. Conclusions: Although hCG injection caused a major change in the gene expression profile of granulosa cells, 10,000 IU hCG resulted in minimal changes in the gene expression profiles of granulosa cells as compared with 5,000 IU. Thus, based on our results, we suggest the use of 10,000 IU hCG should be reconsidered in PCOS patients.

AB - Purpose: Human chorionic gonadotrophin (hCG) has been used to induce ovulation and oocyte maturation. Although the most common dose of hCG used in IVF is 10,000 IU, there are reports that suggest 5,000 IU is sufficient to yield similar results. The objective of this study is to evaluate the dose dependent differences in gene expression of granulosa cells following various doses of hCG treatment. Methods: Patients with polycystic ovarian syndrome (PCOS) were stimulated for IVF treatment. The hCG injection was either withheld or given at 5,000 or 10,000 IU. Granulosa cells from the follicular fluids have been collected for RNA isolation and analyzed using Affymetrix genechip arrays. Results: Unsupervised hierarchical clustering based on whole gene expression revealed two distinct groups of patients in this experiment. All untreated patients were clustered together whereas hCG-treated patients separated to a different group regardless of the dose. A large number of the transcripts were similarly up- or down-regulated across both hCG doses (2229 and 1945 transcripts, respectively). However, we observed dose-dependent statistically significant differences in gene expression in only 15 transcripts. Conclusions: Although hCG injection caused a major change in the gene expression profile of granulosa cells, 10,000 IU hCG resulted in minimal changes in the gene expression profiles of granulosa cells as compared with 5,000 IU. Thus, based on our results, we suggest the use of 10,000 IU hCG should be reconsidered in PCOS patients.

KW - Gene expression

KW - Granulosa cells

KW - Microarray/PCOS

KW - hCG

UR - http://www.scopus.com/inward/record.url?scp=84876296689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876296689&partnerID=8YFLogxK

U2 - 10.1007/s10815-013-9935-y

DO - 10.1007/s10815-013-9935-y

M3 - Article

C2 - 23381551

AN - SCOPUS:84876296689

VL - 30

SP - 341

EP - 352

JO - Journal of Assisted Reproduction and Genetics

JF - Journal of Assisted Reproduction and Genetics

SN - 1058-0468

IS - 3

ER -